Allison Magnan

Allison Magnan is a seasoned professional in GCP Quality Assurance with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as the Director of GCP Quality Assurance at Nuvalent, Inc. since September 2021, Allison has advanced through various roles in multiple organizations, including positions at Blueprint Medicines, CRISPR Therapeutics, Agios Pharmaceuticals, and TESARO, demonstrating a strong background in quality assurance and clinical research. Academic credentials include a degree from Assumption University, which complements a robust career spanning over a decade in clinical research roles at notable companies such as Millennium Pharmaceuticals, Thoratec, Massachusetts General Hospital, and Genzyme.